MERRITT MCLAUGHLIN: Open Payments
NPI 1962797712 · THOMSON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$218 in 11 payments from 8 companies in 2025. Trend: 2023 $205 · 2024 $119 · 2025 $218
Food & beverage: $218
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $39 |
| UCB, Inc. | 1 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| ABBVIE INC. | 2 | $30 |
| Novo Nordisk Inc | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Verona Pharma, Inc. | 1 | $18 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $18 |
Products named: Briviact, CAPLYTA, ZEPBOUND, Ozempic, Kerendia, Ohtuvayre, NEFFY, MOUNJARO.
Industry payments across GA — which companies pay providers there.
